Featured

Antimicrobial Properties of LiDORx®

Antimicrobial Properties of LiDORx®

Antimicrobial Properties of LiDORx® Research Report[1] Assessment of LiDORx® Antimicrobial Activity Against Common Skin Pathogens By: Robert L. Wilbur, PharmD, CPh; David A. Andry, OTR/L Background LiDORx® gel, 3% Lidocaine HCl, combined with Gensco Pharma’s patented...
Physician Explores Gout Treatment Options

Physician Explores Gout Treatment Options

As seen in Chain Drug Review | May 15, 2017 MIAMI — Gout is an extremely painful form of inflammatory arthritis and the most common form of this type of arthritis in men, according to Dr. Gary Myerson, a founding fellow of the American College of Rheumatology....
Advances in Treatment of Painful Wounds

Advances in Treatment of Painful Wounds

by Marc Alan Brenner, DPM, The Institute for Diabetic Foot Research As seen in Podiatry Management | November 2016 Wound management is one of the most common aspects of podiatric practice. The etiology of the wound may vary from post-surgical, traumatic, or disease...
A Review and Case Study of Astero®  (Lidocaine HCl 4%), a New Prescription Hydrogel for Painful Wounds

A Review and Case Study of Astero® (Lidocaine HCl 4%), a New Prescription Hydrogel for Painful Wounds

By Marc A. Brenner, DPM | Podiatry Management, Clinical Innovations, The Diabetic Foot.
Wound pain has numerous, often interlinked, causes that may relate to the initial injury, the inflammatory response or infection. Pain may also result from interventions, such as dressing removal, cleansing, debridement, compression therapy, or topical treatments. Pain as a result of trauma, particularly during the dressing change procedure, has been described by patients as the worst part of dealing with a wound.1

MDose v Tube Study

MDose v Tube Study

MDose™ Technology Background It has been shown that convenience, ease of dispensing and favorable tolerability are key characteristics that may increase patient compliance with topical dermatologic therapy.[1],[2],[3] Additionally, the quantity of drug utilized with...